0.012623 0.007288 0.000000 0.000000 0.014576 0.000000 0.000000 0.000000 0.027112 0.00000 0.00000 0.00000 Wan, Z. Zhao, M. Nakagawa, S. Jia, W. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 18 90.00 90.00 120.00 79.220 79.220 36.884 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C4 H10 N2 O2 118.134 n 2,4-DIAMINOBUTYRIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Zn 2 65.409 ZINC ION non-polymer UK J.Mol.Biol. JMOBAK 0070 0022-2836 315 103 111 10.1006/jmbi.2001.5224 11779231 Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor. 2002 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 97 1999 2004 10.1073/pnas.97.5.1999 Diabetes-associated mutations in a beta-cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface 2000 UK J.Mol.Biol. JMOBAK 0070 0022-2836 284 477 488 10.1006/jmbi.1998.2175 The Relationship Between Insulin Bioactivity and Structure in the NH2-terminal A-chain Helix 1998 UK J.Mol.Biol. JMOBAK 0070 0022-2836 264 390 403 10.1006/jmbi.1996.0648 Mapping the Functional Surface of Insulin by Design: Structure and Function of a Novel A-chain Analogue 1996 NE Biophys.Chem. BICIAZ 0829 0301-4622 50 63 71 10.1016/0301-4622(94)85020-8 A Proposed Interaction Model of the Insulin Molecule with its Receptor 1994 10.2210/pdb1j73/pdb pdb_00001j73 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 mirrors IMAGE PLATE 1998-04-26 RIGAKU RAXIS II Mirrors SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RU200 2382.713 insulin a T8(DAB) 2 syn polymer 3433.953 insulin b 2 syn polymer 65.409 ZINC ION 2 syn non-polymer 18.015 water 95 nat water no yes GIVEQCC(DAB)SICSLYQLENYCN GIVEQCCASICSLYQLENYCN A,C polypeptide(L) no no FVNQHLCGSHLVEALYLVCGERGFFYTPKT FVNQHLCGSHLVEALYLVCGERGFFYTPKT B,D polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 1.91 35.75 VAPOR DIFFUSION, HANGING DROP 6.4 Tris, phonel, acetone, sodium citrate, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K 298 database_2 struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Derived calculations Version format compliance Database references Derived calculations 1 0 2001-05-30 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_conn.conn_type_id _struct_conn.id _struct_conn.pdbx_dist_value _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_asym_id _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_asym_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr1_symmetry _struct_conn.ptnr2_auth_asym_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_asym_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_conn.ptnr2_symmetry _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id 1TRZ contains the same sequence and structure, without substitution of Thr-A8 by diaminobutyric acid COMPOUND THE CONFORMATIONS OF TWO MONOMERS ARE DIFFERENT AS THE RESULT OF A CHANGE IN CONFORMATION OF THE FIRST EIGHT RESIDUES OF THE B-CHAINS. RCSB Y RCSB 2001-05-15 REL ZN ZINC ION HOH water The protein was chemically synthesized. The sequence is naturally found in Homo sapiens(human). sample The protein was chemically synthesized. The sequence is naturally found in Homo sapiens(human). sample ZN 1 3 ZN ZN 31 B ZN 2 3 ZN ZN 31 D HOH 3 4 HOH HOH 22 A HOH 5 4 HOH HOH 23 A HOH 12 4 HOH HOH 24 A HOH 15 4 HOH HOH 25 A HOH 16 4 HOH HOH 26 A HOH 20 4 HOH HOH 27 A HOH 35 4 HOH HOH 28 A HOH 38 4 HOH HOH 29 A HOH 39 4 HOH HOH 30 A HOH 41 4 HOH HOH 31 A HOH 44 4 HOH HOH 32 A HOH 45 4 HOH HOH 33 A HOH 47 4 HOH HOH 34 A HOH 52 4 HOH HOH 35 A HOH 60 4 HOH HOH 36 A HOH 66 4 HOH HOH 37 A HOH 68 4 HOH HOH 38 A HOH 70 4 HOH HOH 39 A HOH 76 4 HOH HOH 40 A HOH 77 4 HOH HOH 41 A HOH 80 4 HOH HOH 42 A HOH 83 4 HOH HOH 43 A HOH 86 4 HOH HOH 44 A HOH 87 4 HOH HOH 45 A HOH 89 4 HOH HOH 46 A HOH 6 4 HOH HOH 32 B HOH 7 4 HOH HOH 33 B HOH 8 4 HOH HOH 34 B HOH 9 4 HOH HOH 35 B HOH 11 4 HOH HOH 36 B HOH 17 4 HOH HOH 37 B HOH 19 4 HOH HOH 38 B HOH 22 4 HOH HOH 39 B HOH 24 4 HOH HOH 40 B HOH 27 4 HOH HOH 41 B HOH 34 4 HOH HOH 42 B HOH 36 4 HOH HOH 43 B HOH 37 4 HOH HOH 44 B HOH 40 4 HOH HOH 45 B HOH 43 4 HOH HOH 46 B HOH 46 4 HOH HOH 47 B HOH 49 4 HOH HOH 48 B HOH 51 4 HOH HOH 49 B HOH 53 4 HOH HOH 50 B HOH 55 4 HOH HOH 51 B HOH 59 4 HOH HOH 52 B HOH 62 4 HOH HOH 53 B HOH 63 4 HOH HOH 54 B HOH 64 4 HOH HOH 55 B HOH 71 4 HOH HOH 56 B HOH 74 4 HOH HOH 57 B HOH 75 4 HOH HOH 58 B HOH 78 4 HOH HOH 59 B HOH 79 4 HOH HOH 60 B HOH 82 4 HOH HOH 61 B HOH 84 4 HOH HOH 62 B HOH 88 4 HOH HOH 63 B HOH 90 4 HOH HOH 64 B HOH 4 4 HOH HOH 22 C HOH 13 4 HOH HOH 23 C HOH 14 4 HOH HOH 24 C HOH 21 4 HOH HOH 25 C HOH 25 4 HOH HOH 26 C HOH 26 4 HOH HOH 27 C HOH 28 4 HOH HOH 28 C HOH 30 4 HOH HOH 29 C HOH 31 4 HOH HOH 30 C HOH 33 4 HOH HOH 31 C HOH 42 4 HOH HOH 32 C HOH 50 4 HOH HOH 33 C HOH 56 4 HOH HOH 34 C HOH 57 4 HOH HOH 35 C HOH 65 4 HOH HOH 36 C HOH 72 4 HOH HOH 37 C HOH 73 4 HOH HOH 38 C HOH 85 4 HOH HOH 39 C HOH 91 4 HOH HOH 40 C HOH 92 4 HOH HOH 41 C HOH 93 4 HOH HOH 42 C HOH 94 4 HOH HOH 43 C HOH 95 4 HOH HOH 44 C HOH 10 4 HOH HOH 32 D HOH 18 4 HOH HOH 33 D HOH 23 4 HOH HOH 34 D HOH 29 4 HOH HOH 35 D HOH 32 4 HOH HOH 36 D HOH 48 4 HOH HOH 37 D HOH 54 4 HOH HOH 38 D HOH 58 4 HOH HOH 39 D HOH 61 4 HOH HOH 40 D HOH 67 4 HOH HOH 41 D HOH 69 4 HOH HOH 42 D HOH 81 4 HOH HOH 43 D HOH 96 4 HOH HOH 44 D HOH 97 4 HOH HOH 45 D GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A DBA 8 n 8 DAB 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B THR 30 n 30 THR 30 B GLY 1 n 1 GLY 1 C ILE 2 n 2 ILE 2 C VAL 3 n 3 VAL 3 C GLU 4 n 4 GLU 4 C GLN 5 n 5 GLN 5 C CYS 6 n 6 CYS 6 C CYS 7 n 7 CYS 7 C DBA 8 n 8 DAB 8 C SER 9 n 9 SER 9 C ILE 10 n 10 ILE 10 C CYS 11 n 11 CYS 11 C SER 12 n 12 SER 12 C LEU 13 n 13 LEU 13 C TYR 14 n 14 TYR 14 C GLN 15 n 15 GLN 15 C LEU 16 n 16 LEU 16 C GLU 17 n 17 GLU 17 C ASN 18 n 18 ASN 18 C TYR 19 n 19 TYR 19 C CYS 20 n 20 CYS 20 C ASN 21 n 21 ASN 21 C PHE 1 n 1 PHE 1 D VAL 2 n 2 VAL 2 D ASN 3 n 3 ASN 3 D GLN 4 n 4 GLN 4 D HIS 5 n 5 HIS 5 D LEU 6 n 6 LEU 6 D CYS 7 n 7 CYS 7 D GLY 8 n 8 GLY 8 D SER 9 n 9 SER 9 D HIS 10 n 10 HIS 10 D LEU 11 n 11 LEU 11 D VAL 12 n 12 VAL 12 D GLU 13 n 13 GLU 13 D ALA 14 n 14 ALA 14 D LEU 15 n 15 LEU 15 D TYR 16 n 16 TYR 16 D LEU 17 n 17 LEU 17 D VAL 18 n 18 VAL 18 D CYS 19 n 19 CYS 19 D GLY 20 n 20 GLY 20 D GLU 21 n 21 GLU 21 D ARG 22 n 22 ARG 22 D GLY 23 n 23 GLY 23 D PHE 24 n 24 PHE 24 D PHE 25 n 25 PHE 25 D TYR 26 n 26 TYR 26 D THR 27 n 27 THR 27 D PRO 28 n 28 PRO 28 D LYS 29 n 29 LYS 29 D THR 30 n 30 THR 30 D author_and_software_defined_assembly PISA,PQS 12 dodecameric 17750 -264 14220 B HIS 10 B NE2 HIS 10 1_555 B ZN 31 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 2_555 102.9 B HIS 10 B NE2 HIS 10 1_555 B ZN 31 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 3_555 102.9 B HIS 10 B NE2 HIS 10 2_555 B ZN 31 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 3_555 102.9 D HIS 10 D NE2 HIS 10 1_555 D ZN 31 F ZN ZN 1_555 D HIS 10 D NE2 HIS 10 2_555 108.7 D HIS 10 D NE2 HIS 10 1_555 D ZN 31 F ZN ZN 1_555 D HIS 10 D NE2 HIS 10 3_555 108.7 D HIS 10 D NE2 HIS 10 2_555 D ZN 31 F ZN ZN 1_555 D HIS 10 D NE2 HIS 10 3_555 108.7 A DAB 8 2,4-DIAMINOBUTYRIC ACID A DAB 8 ALA C DAB 8 2,4-DIAMINOBUTYRIC ACID C DAB 8 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_555 -y,x-y,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 0.8660254038 0.0000000000 -0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 3_555 -x+y,-x,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 B N TYR 26 B N TYR 26 D O PHE 24 D O PHE 24 1 B ZN 31 E ZN 1 D ZN 31 F ZN 1 B B NE2 CD2 HIS HIS 5 5 -0.069 0.011 1.373 1.304 N 1 D D NE2 CD2 HIS HIS 5 5 -0.069 0.011 1.373 1.304 N 1 D D NE2 CD2 HIS HIS 10 10 -0.073 0.011 1.373 1.300 N 0.273 0.205 2.0 10.0 500 5681 5448 9.2 random 1 2.0 1.0 2.0 10.0 95 907 2 0 810 2.0 10.0 1J73 5681 5448 2.0 1.0 0.05 1 3 95.0 0.097 2.0 2.03 1 611 100.0 data reduction DENZO data scaling SCALEPACK model building X-PLOR refinement X-PLOR 3.1 phasing X-PLOR Crystal structure of an unstable insulin analog with native activity. 1 N N 2 N N 1 N N 2 N N 3 N N 3 N N 4 N N 4 N N 4 N N 4 N N A GLY 1 A GLY 1 HELX_P A CYS 7 A CYS 7 1 1 7 A SER 12 A SER 12 HELX_P A GLU 17 A GLU 17 1 2 6 B GLY 8 B GLY 8 HELX_P B GLY 20 B GLY 20 1 3 13 B GLU 21 B GLU 21 HELX_P B GLY 23 B GLY 23 5 4 3 C GLY 1 C GLY 1 HELX_P C CYS 7 C CYS 7 1 5 7 C SER 12 C SER 12 HELX_P C GLU 17 C GLU 17 1 6 6 D ASN 3 D ASN 3 HELX_P D GLY 20 D GLY 20 1 7 18 D GLU 21 D GLU 21 HELX_P D GLY 23 D GLY 23 5 8 3 disulf 2.025 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.003 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.025 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 disulf 2.029 C CYS 6 C SG CYS 6 1_555 C CYS 11 C SG CYS 11 1_555 disulf 2.021 C CYS 7 C SG CYS 7 1_555 D CYS 7 D SG CYS 7 1_555 disulf 2.022 C CYS 20 C SG CYS 20 1_555 D CYS 19 D SG CYS 19 1_555 covale 1.361 both A CYS 7 A C CYS 7 1_555 A DAB 8 A N DAB 8 1_555 covale 1.338 both A DAB 8 A C DAB 8 1_555 A SER 9 A N SER 9 1_555 covale 1.328 both C CYS 7 C C CYS 7 1_555 C DAB 8 C N DAB 8 1_555 covale 1.350 both C DAB 8 C C DAB 8 1_555 C SER 9 C N SER 9 1_555 metalc 2.169 B HIS 10 B NE2 HIS 10 1_555 B ZN 31 E ZN ZN 1_555 metalc 2.169 B HIS 10 B NE2 HIS 10 2_555 B ZN 31 E ZN ZN 1_555 metalc 2.169 B HIS 10 B NE2 HIS 10 3_555 B ZN 31 E ZN ZN 1_555 metalc 2.098 D HIS 10 D NE2 HIS 10 1_555 D ZN 31 F ZN ZN 1_555 metalc 2.098 D HIS 10 D NE2 HIS 10 2_555 D ZN 31 F ZN ZN 1_555 metalc 2.098 D HIS 10 D NE2 HIS 10 3_555 D ZN 31 F ZN ZN 1_555 HORMONE/GROWTH FACTOR A8-Diaminobutyric Acid human insulin, hormone-receptor interface, HORMONE-GROWTH FACTOR COMPLEX INS_HUMAN UNP 1 90 P01308 INS_HUMAN UNP 2 25 P01308 90 110 1J73 1 21 P01308 A 1 1 21 25 54 1J73 1 30 P01308 B 2 1 30 90 110 1J73 1 21 P01308 C 1 1 21 25 54 1J73 1 30 P01308 D 2 1 30 1 THR engineered mutation DAB 8 1J73 A P01308 UNP 97 8 3 THR engineered mutation DAB 8 1J73 C P01308 UNP 97 8 2 anti-parallel B PHE 24 B PHE 24 B TYR 26 B TYR 26 D PHE 24 D PHE 24 D TYR 26 D TYR 26 BINDING SITE FOR RESIDUE ZN B 31 B ZN 31 Software 3 BINDING SITE FOR RESIDUE ZN D 31 D ZN 31 Software 3 B HIS 10 B HIS 10 3 2_555 B HIS 10 B HIS 10 3 3_555 B HIS 10 B HIS 10 3 1_555 D HIS 10 D HIS 10 3 2_555 D HIS 10 D HIS 10 3 1_555 D HIS 10 D HIS 10 3 3_555 146 H 3